Latest news
FDA investigate potential Stargardt treatment
Posted: Monday 13 November 2017
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a drug to help treat Stargardt disease, according to Lin BioScience.The drug, known as LBS-008, is designed to prevent the build-up of a toxin in the eye called lipofuscin…
Find out more
Do you want a place in the London Marathon?
Posted: Wednesday 8 November 2017
Have you always wanted to run the London Marathon but struggled to get a place?Now could be your chance to do just that, while raising vital funds for people with macular disease.The Macular Society has a coveted place in next year’s race and is calling …
Find out more
Eylea approved for myopic CNV patients
Posted: Wednesday 1 November 2017
The National Institute of Health and Care Excellence (NICE) has recommended the use of Eylea® on adults for treating visual impairment due to myopic chorodial neovascularisation (CNV).Pathological myopia, also known as severe near sightedness, affects 3%…
Find out more
Drug companies threaten legal fight over cheaper drug
Posted: Wednesday 1 November 2017
Health chiefs face a legal fight over plans to give a cheap drug to patients with wet age-related macular degeneration (AMD).
Find out more
Simplyhealth funds counselling service for people with sight loss
Posted: Tuesday 31 October 2017
Simplyhealth has donated £30,000 to the Macular Society to help people with macular disease gain access to vital counselling services.The Macular Society, the national sight loss charity, offers free telephone counselling by accredited counsellors which …
Find out more
Eye bank levels fall below level needed
Posted: Monday 30 October 2017
NHS Blood and Transplant (NHSBT) has revealed that its eye banks are 21% below the level needed to supply hospitals, leading to delays in cornea transplant operations.At the end of September, there were 278 corneas in the service’s Manchester and Bristol…
Find out more
Your questions answered
Posted: Thursday 26 October 2017
On Monday we ran out of time to ask all of your questions as part of our Charles Bonnet Twitter Q&A.
Find out more
Charles Bonnet Q&A
Posted: Monday 23 October 2017
As part of our Charles Bonnet campaign, Dr John-Paul Taylor, Clinical Senior Lecturer and Consultant from the Newcastle University took part in a live Twitter question and answer session.If you were unable to join the session, please find the full Q&A; s…
Find out more
Take part in a research study
Posted: Friday 13 October 2017
Researchers at Aston University are inviting those that are sight impaired and severely impaired in the UK, to take part in a study investigating the impact of vision loss on diet and appetite.Participants will complete a telephone questionnaire, which w…
Find out more
Get your Charles Bonnet questions answered
Posted: Wednesday 11 October 2017
On Monday 23 October we will be hosting our first live Twitter Q&A; to answer your questions about visual hallucinations, known as Charles Bonnet Syndrome.
Find out more
Four people “go blind” waiting for NHS treatment in Cornwall
Posted: Thursday 5 October 2017
The Royal Cornwall Hospitals NHS Trust has been placed in special measures, after inspectors from the Care Quality Commission (CQC) found that at least four patients had suffered significant sight loss while waiting for treatment for age-related macular …
Find out more
European project aims to find new tests and treatments for AMD
Posted: Friday 29 September 2017
A new European-wide project is aiming to develop tests and therapies for age-related macular degeneration (AMD).The Macustar project involves researchers from City, University of London, University College London (UCL) and Moorfields Eye Hospital.The £14…
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter